Stability of CXCL-8 and related AU-rich mRNAs in the context of hepatitis C virus replication in vitro

Journal of Infectious Diseases

Volumn 193, Issue 6, 2006, Pages 802-811

  Green, Jamison ^a   Khabar, Khalid S A ^c   Koo, Bon Chang A ^a,d   Williams, Bryan R G ^b   Polyak, Stephen J ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Virology Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DNA PROBE; GENE EXPRESSION REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; RNA TRANSLATION; VIRUS REPLICATION;

ADENINE; CELL LINE; CHEMOKINES, CXC; GENE EXPRESSION; HEPACIVIRUS; HUMANS; PEPTIDE FRAGMENTS; RNA STABILITY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; URIDINE; VIRUS REPLICATION;

EID: 33644886001     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500510     Document Type: Article

References (49)

1. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6:35-47.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20:1-16.
3. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection-host, viral, and environmental factors. JAMA 2000; 284:450-6.
4. Polyak SJ. Hepatitis C virus-cell interactions and their role in pathogenesis. Clin Liver Dis 2003; 7:67-88.
5. Gale M, Blakely CM, Kwieciszewski B, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 1998; 18:5208-18.
6. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334:77-81.
7. Nousbaum J, Polyak SJ, Ray SC, et al. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J Virol 2000; 74:9028-38.
8. Polyak SJ, Khabar KS, Paschal DM, et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001; 75:6095-106.
9. Girard S, Shalhoub P, Lescure P, et al. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 2002; 295:272-83.
10. Bonte D, Francois C, Castelain S, et al. Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication. Arch Virol 2004; 149:1353-71.
11. Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 2003; 96:27-35.
12. Khabar KS, Al-Zoghaibi F, Al-Ahdal MN, et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J Exp Med 1997; 186:1077-85.
13. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72:391-8.
14. Polyak SJ, Khabar KS, Rezeiq M, Gretch DR. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 2001; 75:6209-11.
15. Mihm S, Herrmann E, Sarrazin U, et al. Association of serum interlukin-8 with virologicresponse to antiviral therapy in patients with chronic hepatitis C. J Hepatol 2004; 40:845-52.
16. Leland Booth J, Metcalf JP. Type-specific induction of interleukin-8 by adenovirus. Am J Respir Cell Mol Biol 1999; 21:521-7.
17. Winzen R, Kracht M, Ritter B, et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 1999; 18:4969-80.
18. Holtmann H, Winzen R, Holland P, et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 1999; 19:6742-53.
19. Bakheet T, Frevel M, Williams BRG, Greer W, Khabar KSA. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional reportiore of encoded proteins. Nucleic Acids Res 2001; 29:246-54.
20. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995; 20:465-70.
21. Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci 2001; 58:266-77.
22. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46:659-67.
23. Frevel MAE, Bakheet T, Silva AM, Hissong JG, Khabar KSA, Williams BRG. p38 MAP kinase dependent and independent signaling of mRNA stability of AU-rich element containing transcripts. Mol Cell Biol 2003; 23:425-36.
24. Khabar KS, Polyak SJ. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. J Interferon Cytokine Res 2002; 22:1005-12.
25. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:1972-4.
26. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002; 76:13001-14.
27. Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 2001; 75:4614-24.
28. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285:110-3.
29. Lohmann V, Korner F, Dobierzewska A, Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 2001; 75:1437-49.
30. Lazaro CA, Croager EJ, Mitchell C, et al. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 2003; 38:1095-106.
31. Romppanen EL, Savolainen K, Mononen I. Optimal use of the fluorescent PicoGreen dye for quantitative analysis of amplified polymerase chain reaction products on microplate. Anal Biochem 2000; 279:111-4.
32. Vandenbroucke II, Vandesompele J, Paepe AD, Messiaen L. Quantification of splice variants using real-time PCR. Nucleic Acids Res 2001; 29:E68-8.
33. Khabar KS, Siddiqui YM, al-Zoghaibi F, et al. RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. J Biol Chem 2003; 278:20124-32.
34. Khabar KS, Al-Haj L, Al-Zoghaibi F, et al. Expressed gene clusters associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon. J Mol Biol 2004; 342:833-46.
35. Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR. p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 2003; 23:425-36.
36. Roger T, Out T, Mukaida N, Matsushima K, Jansen H, Lutter R. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem J 1998; 330:429-35.
37. Hassan M, Ghozlan H, Abdel-Kader O. Activation of c-Jun NH(2)-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 2005; 333:324-36.
38. Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 2003; 278:35755-66.
39. Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J Biol Chem 2003; 278:40778-87.
40. Sumpter R Jr, Loo YM, Foy E, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005; 79:2689-99.
41. Haskill S, Peace A, Morris J, et al. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci USA 1990; 87:7732-6.
42. Heyninck K, De Valck D, Vanden Berghe W, et al. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB- inhibiting protein ABIN. J Cell Biol 1999; 145:1471-82.
43. Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA 1996; 93:6721-5.
44. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180:86-99.
45. Mbow ML, Sarisky RT. What is disrupting IFN-alpha's antiviral activity? Trends Biotechnol 2004; 22:395-9.
46. Peng SS, Chen CY, Xu N, Shyu AB. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 1998; 17:3461-70.
47. Wong GH, Krowka JF, Stites DP, Goeddel DV. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol 1988; 140:120-4.
48. Wong GH, Goeddel DV. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 1986; 323:819-22.
49. Hoshida Y, Kato N, Yoshida H, et al. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8. J Infect Dis 2005; 192:266-75.